Soon, technological advances will help us understand this critical pathway for cervical cancer development, including cell-extrinsic and cell-intrinsic factors that regulate JAK/STAT activity, as well as the molecular mechanisms of dysregulated JAK/STAT signaling which could help us find specific targets to inhibit the pathway, leading to more efficient and less severe cancer treatments. The gene discussed is SOAT1; the disease is cervical carcinoma.